BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Cadent Therapeutics Appoints John McBride as Chief Financial Officer and Expands its Leadership Team

  Cadent Therapeutics announced the appointment of seasoned executive, John McBride, as Chief Financial Officer.

  August 21, 2019

   · 

  5 min read
• Business

  Insurance Care Direct Adds David Corsaut as Chief Strategy Officer

  Insurance Care Direct (ICD), one of the nation’s largest health and life insurance agencies, today announced that David Corsaut has joined the Company as Chief Strategy Officer.

  August 21, 2019

   · 

  4 min read
• Business

  CDPHP Partners with Valera Health to Break the Boundaries of Traditional Mental Health and Substance Use Treatment

  Capital District Physicians’ Health Plan, Inc. (CDPHP) and Valera Health are pleased to announce a multi-year alliance that will expand member access to high-quality mental health and substance use case management services.

  August 21, 2019

   · 

  3 min read
• Job Trends

  2019 Patient Flow Summit Sponsored by Central Logic to Feature the Evolution of the Transfer Center

  Central Logic, the leading innovator in transfer center software solutions, announced that its 2019 Patient Flow Summit next month will feature a live Access Center.

  August 21, 2019

   · 

  4 min read
• Business

  Rebiotix, Inc and Karolinska Institutet Expand Partnership to Shape the Future of Microbiome Research

  Rebiotix Inc, a Ferring Pharmaceuticals company, announced today that their Chief Scientific Officer, Dr. Ken Blount, has been appointed to Karolinska Institutet’s Joint Steering Committee (JSC) of the Centre for Translation Microbiome Research (CTMR) in Stockholm, Sweden.

  August 21, 2019

   · 

  3 min read
• Biotech Beach

  Cidara Therapeutics to Present Data from its Cloudbreak Antiviral Program at the Options X for the Control of Influenza Conference

  Five abstracts, including one late-breaker, highlighting data from its Cloudbreak® antiviral program have been accepted for presentation at the Options X for the Control of Influenza conference taking place August 28-September 1 in Singapore.

  August 21, 2019

   · 

  7 min read
• Drug Development

  ChemomAb Ltd., Announces Data from Phase 1 Study of CM-101 Subcutaneous Formulation Demonstrating Comparable Exposure to The Intravenous CM-101 Formulation

  CM-101 was safe and well tolerated using both IV and SC formulations

  August 21, 2019

   · 

  2 min read
• Job Trends

  Tissue Genesis’ Icellator® X Delivers Results in First Clinical Application

  Tissue Genesis, a leading developer of cell therapy processing systems, announced today that an initial group of patients was successfully treated in the first clinical application of its Icellator® X technology at the Okyanos Center for Regenerative Medicine in Freeport, Bahamas

  August 21, 2019

   · 

  3 min read
• BioMidwest

  Escalent Explores the Systemic Nature of America’s Opioid Crisis

  Escalent, a top human behavior and analytics firm, today published a study examining the nationwide opioid crisis through the lens of consumer attitudes.

  August 21, 2019

   · 

  2 min read
• Pharm Country

  Bureau Veritas Becomes the First Accredited Canadian Laboratory For Environmental DNA (eDNA) Testing

  Bureau Veritas, a world-leader in testing, inspection, and certification (TIC) services, today announced it has met rigorous ISO 17025 standards to become the first Canadian laboratory to receive accreditation for eDNA testing from the Standards Council of Canada.

  August 21, 2019

   · 

  2 min read